| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_132aa5ddba376cda52c2bedb26765245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate |
2008-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80dcb11dac33ecc8a4ca9b6282767a9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70b36d212c6fe772f81ef91abb8186bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cb3daf9e9e0f212f18e65d9a79b4103
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39039119160cd876e5c2ccd063e91723
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6774ede5c8a12b79c2bf8e02c264bc5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e915fd13e5646f9ee4b18772ff546f51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1dca3819a1205f8e1521a5c5b61468e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2682018f6c1ee7554d7176b55166382 |
| publicationDate |
2013-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2708418-C |
| titleOfInvention |
Oxazolidinones for the treatment and/or prophylaxis of heart failure |
| abstract |
The present invention relates to the use of selective inhibitors of coagulation factor Xa, in particular of oxazolidinones of the formula (I), for the treatment and/or prophylaxis of heart failure and/or disorders related to heart failure as well as their use for the preparation of pharmaceutical drugs for the treatment and/or prophylaxis of heart failure and/or disorders related to heart failure. |
| priorityDate |
2007-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |